THINK Surgical Receives FDA 510(k) Clearance to use Freedom® Total Knee, Freedom Titan® Knee, and Freedom Primary PCK® System implants with TMINI® Miniature Robotic System

FREMONT, Calif., Nov. 19, 2024 /PRNewswire/ — THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced that its TMINI® Miniature Robotic System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with the Freedom Total Knee, Freedom Titan Knee, and Freedom Primary PCK Systems from Maxx Orthopedics, Inc. (Norristown, PA) under a Collaboration Agreement between the two companies.

The Freedom Total Knee, Freedom Titan Knee, and Freedom Primary PCK Systems have been added to THINK Surgical’s ID-HUB™, a proprietary data bank of implant modules for use with the open platform version of its TMINI System in the United States.

The Freedom Total Knee and Freedom Titan Knee Systems feature a multi-radius design that accommodates individual patient anatomy, potentially leading to improved alignment and positioning for long-term success. It offers an enhanced range of motion that can achieve flexion up to 155 degrees to help improve functional outcomes for active lifestyles after surgery. Clinically, it has demonstrated strong performance and durability with a 10-year survivorship of 98.3%1.

“Maxx Orthopedics believes in great partnerships and is excited surgeons will have the ability to perform robotic-assisted TKA procedures with our Freedom Total Knee System. Combining our knee solutions with the TMINI System, surgeons can choose from multiple implant options- standard materials to metal sensitivity solutions- and seamlessly perform conventional or robotic-assisted procedures,” said Ashesh Shah, chief executive officer of Maxx Orthopedics. 

“THINK Surgical is excited to offer the TMINI System for use with the Freedom Knee System. The open platform version of TMINI is now available with eight different knee designs from eight separate orthopedic companies offering surgeons the choice of single-radius, anatomic (multi-radius), and guided motion knees on a single robotic platform” said Stuart Simpson, president, and chief executive officer of THINK Surgical. 

References

1. Durbhakula S, Rego L, Eberle R: Restoration of Femoral Condylar Anatomy for Achieving Optimum Functional Expectations: Continuation of Earlier Studies at 10-Years follow-up. J Orthop Exp Innovation, [Accepted for Publication], 2024.

About THINK Surgical, Inc.

THINK Surgical, Inc., is a privately held U.S.-based technology innovator that develops and markets orthopedic robots.

THINK Surgical actively collaborates with healthcare professionals to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent technology.  Please refer to the instructions for use for the TMINI Miniature Robotic System for a complete list of indications, contraindications, warnings, and precautions. For additional product information, please visit www.thinksurgical.com.  

THINK Surgical and TMINI are trademarks of THINK Surgical, Inc. 

About Maxx Orthopedics

Maxx Orthopedics is the manufacturer of the Freedom Total Knee System, Freedom Titan Knee System, Freedom PCK System, Libertas® Total Hip System, and Quick Recovery Solutions (QRS®). The company develops and markets innovative orthopedic medical devices worldwide with a focus on providing state-of-the-art implants and related solutions that best restore patient mobility while accommodating lifestyle, anatomical and economic needs. Discover more at www.maxxortho.com/ and follow us on LinkedIn, X, Instagram, and Facebook.  

Media Contacts:

THINK Surgical                                                                   Maxx Orthopedics, Inc.      

Nick Margree                                                                        Donald Montgomery

nmargree@thinksurgical.com                                             info@maxxortho.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/think-surgical-receives-fda-510k-clearance-to-use-freedom-total-knee-freedom-titan-knee-and-freedom-primary-pck-system-implants-with-tmini-miniature-robotic-system-302308339.html

SOURCE THINK Surgical, Inc.

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

14 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

14 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago